BASTEI LUBBE AG (BST.DE) Fundamental Analysis & Valuation

Name: BASTEI LUBBE AG (BST.DE) Fundamental Analysis Rating
Brand: BASTEI LUBBE AG

FRA:BST • DE000A1X3YY0

6.76 EUR

+0.18 (+2.74%)

Last: Mar 25, 2026, 07:00 PM

This BST.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1. BST.DE Profitability Analysis

1.1 Basic Checks

In the past year BST was profitable.
BST had a negative operating cash flow in the past year.
In the past 5 years BST has always been profitable.
BST had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

The Return On Assets of BST (7.78%) is better than 92.42% of its industry peers.
BST has a better Return On Equity (13.88%) than 78.79% of its industry peers.
Looking at the Return On Invested Capital, with a value of 11.80%, BST belongs to the top of the industry, outperforming 89.39% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BST is above the industry average of 7.69%.
The 3 year average ROIC (11.74%) for BST is below the current ROIC(11.80%), indicating increased profibility in the last year.

		Industry Rank	Sector Rank
ROA	7.78%
ROE	13.88%
ROIC	11.8%

ROA(3y)7.31%

ROA(5y)8.15%

ROE(3y)12.63%

ROE(5y)15.01%

ROIC(3y)11.74%

ROIC(5y)11.8%

1.3 Margins

BST's Profit Margin of 8.23% is amongst the best of the industry. BST outperforms 81.82% of its industry peers.
In the last couple of years the Profit Margin of BST has declined.
The Operating Margin of BST (11.41%) is better than 71.21% of its industry peers.
In the last couple of years the Operating Margin of BST has grown nicely.
BST has a Gross Margin (51.60%) which is in line with its industry peers.
BST's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	11.41%
PM (TTM)	8.23%
GM	51.6%

OM growth 3Y5.11%

OM growth 5Y25.16%

PM growth 3Y-4.99%

PM growth 5YN/A

GM growth 3Y1.19%

GM growth 5Y3.74%

More info and screens

ROA ROE ROIC Operating and Profit Margin Show most profitable peers

2. BST.DE Health Analysis

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BST is creating some value.
BST has about the same amout of shares outstanding than it did 1 year ago.
BST has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, BST has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 2.88 indicates that BST is not a great score, but indicates only limited risk for bankruptcy at the moment.
BST has a better Altman-Z score (2.88) than 95.45% of its industry peers.
BST has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.05, BST belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.05
Debt/FCF	N/A
Altman-Z	2.88

ROIC/WACC1.65

WACC7.14%

2.3 Liquidity

A Current Ratio of 1.46 indicates that BST should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.46, BST is doing good in the industry, outperforming 77.27% of the companies in the same industry.
A Quick Ratio of 1.07 indicates that BST should not have too much problems paying its short term obligations.
BST's Quick ratio of 1.07 is fine compared to the rest of the industry. BST outperforms 71.21% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.46
Quick Ratio	1.07

More info and screens

WACC Debt/Equity How to determine the health of a company Altman-Z score Show peers with great health

3. BST.DE Growth Analysis

3.1 Past

BST shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.98%.
The Earnings Per Share has been growing slightly by 1.14% on average over the past years.
The Revenue has decreased by -0.79% in the past year.
Measured over the past years, BST shows a small growth in Revenue. The Revenue has been growing by 6.95% on average per year.

EPS 1Y (TTM)-10.98%

EPS 3Y1.14%

EPS 5YN/A

EPS Q2Q%-32.37%

Revenue 1Y (TTM)-0.79%

Revenue growth 3Y6.45%

Revenue growth 5Y6.95%

Sales Q2Q%3.3%

3.2 Future

The Earnings Per Share is expected to decrease by -1.18% on average over the next years.
Based on estimates for the next years, BST will show a small growth in Revenue. The Revenue will grow by 0.99% on average per year.

EPS Next Y-9.69%

EPS Next 2Y0.19%

EPS Next 3Y-1.18%

EPS Next 5YN/A

Revenue Next Year2.05%

Revenue Next 2Y2.22%

Revenue Next 3Y2.2%

Revenue Next 5Y0.99%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks Show best growing peers

4. BST.DE Valuation Analysis

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.90, the valuation of BST can be described as very reasonable.
BST's Price/Earnings ratio is a bit cheaper when compared to the industry. BST is cheaper than 66.67% of the companies in the same industry.
When comparing the Price/Earnings ratio of BST to the average of the S&P500 Index (25.61), we can say BST is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 7.75, the valuation of BST can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BST indicates a somewhat cheap valuation: BST is cheaper than 75.76% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.79. BST is valued rather cheaply when compared to this.

		Industry Rank	Sector Rank
PE	10.9
Fwd PE	7.75

4.2 Price Multiples

BST's Enterprise Value to EBITDA ratio is in line with the industry average.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	5.93

4.3 Compensation for Growth

The decent profitability rating of BST may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y0.19%

EPS Next 3Y-1.18%

More info and screens

Price/Earnings Price/FCF FCF per share EV/EBITDA PEG RATIO Show best valued peers

5. BST.DE Dividend Analysis

5.1 Amount

With a Yearly Dividend Yield of 5.39%, BST is a good candidate for dividend investing.
In the last 3 months the price of BST has falen by -21.94%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 3.53, BST pays a bit more dividend than its industry peers.
BST's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.

		Industry Rank	Sector Rank
Dividend Yield	5.39%

5.2 History

On average, the dividend of BST grows each year by 156.54%, which is quite nice.

Dividend Growth(5Y)156.54%

Div Incr Years1

Div Non Decr Years1

5.3 Sustainability

BST pays out 50.46% of its income as dividend. This is a bit on the high side, but may be sustainable.
BST's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.

DP50.46%

EPS Next 2Y0.19%

EPS Next 3Y-1.18%

More info and screens

Find the best dividend stocks Show peers with best dividend

BST.DE Fundamentals: All Metrics, Ratios and Statistics

BASTEI LUBBE AG

FRA:BST (3/25/2026, 7:00:00 PM)

6.76

+0.18 (+2.74%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryMedia

Earnings (Last)02-05 2026-02-05

Earnings (Next)07-13 2026-07-13

Inst Owners5.35%

Inst Owner ChangeN/A

Ins Owners39.08%

Ins Owner ChangeN/A

Market Cap89.91M

Revenue(TTM)115.55M

Net Income(TTM)9.42M

Analysts87.5

Price Target12.39 (83.28%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	5.39%

Yearly Dividend0.3

Dividend Growth(5Y)156.54%

DP50.46%

Div Incr Years1

Div Non Decr Years1

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-6.18%

PT rev (3m)-6.18%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-3.32%

EPS NY rev (3m)-3.32%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-0.82%

Revenue NY rev (3m)-1.36%

Valuation

		Industry Rank	Sector Rank
PE	10.9
Fwd PE	7.75
P/S	0.79
P/FCF	N/A
P/OCF	N/A
P/B	1.32
P/tB	1.47
EV/EBITDA	5.93

EPS(TTM)0.62

EY9.17%

EPS(NY)0.87

Fwd EY12.9%

FCF(TTM)-0.62

FCFYN/A

OCF(TTM)-0.47

OCFYN/A

SpS8.6

BVpS5.1

TBVpS4.6

PEG (NY)N/A

PEG (5Y)N/A

Graham Number8.44

Profitability

		Industry Rank	Sector Rank
ROA	7.78%
ROE	13.88%
ROCE	17.42%
ROIC	11.8%
ROICexc	12.87%
ROICexgc	14.25%
OM	11.41%
PM (TTM)	8.23%
GM	51.6%
FCFM	N/A

ROA(3y)7.31%

ROA(5y)8.15%

ROE(3y)12.63%

ROE(5y)15.01%

ROIC(3y)11.74%

ROIC(5y)11.8%

ROICexc(3y)15.22%

ROICexc(5y)15.52%

ROICexgc(3y)17.65%

ROICexgc(5y)18.64%

ROCE(3y)17.34%

ROCE(5y)17.43%

ROICexgc growth 3Y-3.07%

ROICexgc growth 5Y16.83%

ROICexc growth 3Y1.69%

ROICexc growth 5Y15.18%

OM growth 3Y5.11%

OM growth 5Y25.16%

PM growth 3Y-4.99%

PM growth 5YN/A

GM growth 3Y1.19%

GM growth 5Y3.74%

F-Score3

Asset Turnover0.94

Health

		Industry Rank	Sector Rank
Debt/Equity	0.05
Debt/FCF	N/A
Debt/EBITDA	0.24
Cap/Depr	73.65%
Cap/Sales	1.69%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.46
Quick Ratio	1.07
Altman-Z	2.88

F-Score3

WACC7.14%

ROIC/WACC1.65

Cap/Depr(3y)46.32%

Cap/Depr(5y)34.22%

Cap/Sales(3y)1.19%

Cap/Sales(5y)0.89%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-10.98%

EPS 3Y1.14%

EPS 5YN/A

EPS Q2Q%-32.37%

EPS Next Y-9.69%

EPS Next 2Y0.19%

EPS Next 3Y-1.18%

EPS Next 5YN/A

Revenue 1Y (TTM)-0.79%

Revenue growth 3Y6.45%

Revenue growth 5Y6.95%

Sales Q2Q%3.3%

Revenue Next Year2.05%

Revenue Next 2Y2.22%

Revenue Next 3Y2.2%

Revenue Next 5Y0.99%

EBIT growth 1Y-16.35%

EBIT growth 3Y11.89%

EBIT growth 5Y33.86%

EBIT Next Year-3.75%

EBIT Next 3Y4.01%

EBIT Next 5YN/A

FCF growth 1Y-228.09%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-193.21%

OCF growth 3YN/A

OCF growth 5YN/A

BASTEI LUBBE AG / BST.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BASTEI LUBBE AG (BST.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to BST.DE.

What is the valuation status of BASTEI LUBBE AG (BST.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to BASTEI LUBBE AG (BST.DE). This can be considered as Fairly Valued.

Can you provide the profitability details for BASTEI LUBBE AG?

BASTEI LUBBE AG (BST.DE) has a profitability rating of 7 / 10.

What is the valuation of BASTEI LUBBE AG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BASTEI LUBBE AG (BST.DE) is 10.9 and the Price/Book (PB) ratio is 1.32.

How financially healthy is BASTEI LUBBE AG?

The financial health rating of BASTEI LUBBE AG (BST.DE) is 5 / 10.